MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240182519A1
SERIAL NO

18142621

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to peptide ligands of the melanocortin receptors, in particular the melanocortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IPSEN PHARMA S A S65 QUAI GEORGES GORSE BOULOGNE-BILLANCOURT 92100

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Comstock, Jeanne Mary West Boylston, US 10 37
Deoliveira, Daniel B Bellingham, US 10 32
Dong, Zheng Xin Holliston, US 114 936

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation